Tower Research Capital (TRC)’s Jasper Therapeutics JSPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8K | Buy |
3,747
+1,259
| +51% | +$6.99K | ﹤0.01% | 3658 |
|
|
2025
Q1 | $10.7K | Buy |
2,488
+933
| +60% | +$4.01K | ﹤0.01% | 3613 |
|
|
2024
Q4 | $33.2K | Buy |
1,555
+860
| +124% | +$18.4K | ﹤0.01% | 2829 |
|
|
2024
Q3 | $13.1K | Buy |
+695
| New | +$13.1K | ﹤0.01% | 3544 |
|
|
2024
Q1 | – | Sell |
-1,114
| Closed | -$8.79K | – | 6017 |
|
|
2023
Q4 | $8.79K | Buy |
+1,114
| New | +$8.79K | ﹤0.01% | 4463 |
|
|
2023
Q3 | – | Sell |
-940
| Closed | -$12.9K | – | 6085 |
|
|
2023
Q2 | $12.9K | Buy |
+940
| New | +$12.9K | ﹤0.01% | 3799 |
|
|
2023
Q1 | – | Sell |
-1,284
| Closed | -$6K | – | 6069 |
|
|
2022
Q4 | $6K | Sell |
1,284
-84
| -6% | -$393 | ﹤0.01% | 4731 |
|
|
2022
Q3 | $11K | Buy |
1,368
+907
| +197% | +$7.29K | ﹤0.01% | 4447 |
|
|
2022
Q2 | $9K | Buy |
461
+325
| +239% | +$6.35K | ﹤0.01% | 4566 |
|
|
2022
Q1 | $5K | Sell |
136
-155
| -53% | -$5.7K | ﹤0.01% | 5061 |
|
|
2021
Q4 | $23K | Sell |
291
-604
| -67% | -$47.7K | ﹤0.01% | 3515 |
|
|
2021
Q3 | $92K | Buy |
895
+890
| +17,800% | +$91.5K | ﹤0.01% | 2469 |
|
|
2021
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 5215 |
|
|
2021
Q1 | $1K | Sell |
5
-35
| -88% | -$7K | ﹤0.01% | 5187 |
|
|
2020
Q4 | $4K | Buy |
+40
| New | +$4K | ﹤0.01% | 4718 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4955 |
|